- Home
- / Kane Biotech
Kane Biotech
Stock Price
$0.1
2024-10-29
Market Capitalization
$16.6 M
2024-10-29
Revenue
$427 K
FY, 2025
Kane Biotech Summary
Company Summary
- Overview
- Kane Biotech is a biotechnology company engaged in the research, development, and commercialization of technologies dispersing biofilms. It discovers and commercializes technologies that prevent biofilm-related infections in human and animal healthcare as well as biofilm-related problems in industrial applications.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Winnipeg, CA | view all locations
- Website
- https://kanebiotech.com/
- Cybersecurity rating
Table of Contents
Key People
Ray Dupuis, Chief Financial Officer
Marc Edwards, President, Chief Executive Officer, Director
Nanda Yakandawala, Vice President, Research and Development
LocationsView all
2 locations detected
Winnipeg, MB HQ
Canada
162-196 Innovation Dr
Winnipeg, MB
Canada
290 Innovation Dr
Kane Biotech Financials
Summary Financials
- Revenue (FY, 2025)
- $C427.0K
- Gross profit (FY, 2025)
- $C161.0K
- Net income (FY, 2025)
- ($C2.7M)
- Cash (FY, 2025)
- $C901.0K
- EBIT (FY, 2025)
- ($C2.6M)
- Enterprise value
- $17.5M